ENZ

Enzo Biochem
NYSE

Real-time Quotes | Nasdaq Last Sale

2.510
-0.130
-4.92%
Pre Market: 2.580 +0.07 +2.79% 09:06 07/16 EDT
OPEN
2.640
PREV CLOSE
2.640
HIGH
2.650
LOW
2.500
VOLUME
106.26K
TURNOVER
--
52 WEEK HIGH
4.850
52 WEEK LOW
1.560
MARKET CAP
120.21M
P/E (TTM)
-3.9103
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ENZ stock price target is 5.50 with a high estimate of 5.50 and a low estimate of 5.50.

EPS

ENZ News

More
FDA OKs emergency use of Enzo Bio's COVID-19 test
Enzo Biochem (NYSE:ENZ) soared 21% yesterday as its Ampiprobe SARS-CoV-2 Test System was granted Emergency Use Authorization by the FDA in a letter. The le
seekingalpha · 6d ago
CLNE, NTES among premarket gainers
Seeking Alpha - Article · 07/09 12:19
Enzo Biochem's COVID test granted emergency authorization from the FDA
Seeking Alpha - Article · 07/09 10:58
Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus
GlobeNewswire · 06/30 18:15
Should You Avoid Enzo Biochem, Inc. (ENZ)?
Insider Monkey · 06/25 22:50
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I
GlobeNewswire · 06/23 13:30
Enzo Announces Issuance Of U.S. Patent for Methods Of Treating Liver Cancer Using Proprietary Compound SK1-I
Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK,
Benzinga · 06/23 12:31
Edited Transcript of ENZ earnings conference call or presentation 8-Jun-20 9:00pm GMT
Thomson Reuters StreetEvents · 06/10 09:57

Industry

Healthcare Facilities & Services
+3.21%
Healthcare Providers & Services
+0.75%

Hot Stocks

Symbol
Price
%Change

About ENZ

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or procedures. Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers. Enzo Therapeutics is a biopharmaceutical venture that develops multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Its products in the development pipeline include a range of assays for detection of various women's health infectious agents, as well as for use in the identification of pathogens for other markets.
More

Webull offers kinds of Enzo Biochem, Inc. stock information, including NYSE:ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.